Carina Biotech
Adelaide, AU · Founded 2016 · 16 employees on LinkedIn · 1 known investors
Carina Biotech develops chimeric antigen receptor T cell (CAR-T) therapies and other adoptive cell therapies to treat solid cancers using a patient's immune system. The Australian clinical-stage immunotherapy company creates patient-specific treatments with proprietary platforms designed to improve access to tumors and enhance cell manufacturing.
Founders & leadership
SB
Simon BarryChief Medical Scientist
DD
Dr Deborah RathjenChief Executive Officer & Managing Director
PS
Professor Shaun McCollChief Scientific Officer
Board
CB
Claudine BonderHead, Vascular Biology and Cell Trafficking Laboratory
Investors · 1
Frequently asked questions
- What does Carina Biotech do?
- Carina Biotech develops chimeric antigen receptor T cell (CAR-T) therapies and other adoptive cell therapies to treat solid cancers using a patient's immune system. The Australian clinical-stage immunotherapy company creates patient-specific treatments with proprietary platforms designed to improve access to tumors and enhance cell manufacturing.
- Who are Carina Biotech's investors?
- Carina Biotech's investors include Tenmile.
- Where is Carina Biotech headquartered?
- Carina Biotech is headquartered in Adelaide, AU.